Narnolia

Narnolia

Toll Free No: 1800-103-7212

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE391.300.9 (+0.23 %)
PREV CLOSE ( ) 390.40
OPEN PRICE ( ) 396.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2675
TODAY'S LOW / HIGH ( )378.00 396.00
52 WK LOW / HIGH ( )247.3 660
NSE390.15-0.1 (-0.03 %)
PREV CLOSE( ) 390.25
OPEN PRICE ( ) 399.85
BID PRICE (QTY) 390.15 (110)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34199
TODAY'S LOW / HIGH( ) 385.05 399.85
52 WK LOW / HIGH ( )245.75 662
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Rama Mohan Rao - Managing Director
Registered Office

Address Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-30211600

Email ir@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
08May Reliance Industries, Neuland Laborator
Vista Equity Partners (Vista) will invest Rs 11,367 crore into Reliance..
08May Neuland Laboratories receives EIR from
Neuland Laboratories has received Establishment Inspection Report (EIR)..
08May Neuland Laboratories jumps on receivin
Neuland Laboratories is currently trading at Rs. 437.00, up by 19.55 poi..
23Apr Neuland Laboratories submits RTA certi
Neuland Laboratories has informed about submission of certificate as req..
10Feb Neuland Laboratories gets two observat
The United States Food and Drug Administration (USFDA) has inspected one..
Financials
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit-93.5099999999999158.81
Gross Profit 170.76 524.97
Operating Profit 317.71053.44
Net Sales 1918.667627.11
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
peergroup  4297.80 (4.59%)
M.Cap ( in Cr)7134.08
Piramal Enterprises (BSE)
peergroup  1113.40 (14.74%)
M.Cap ( in Cr)25111.43
Divis Lab (BSE)
peergroup  2481.10 (3.56%)
M.Cap ( in Cr)65865.41
Abbott India (BSE)
peergroup  16813.15 (0.51%)
M.Cap ( in Cr)35726.77
Sanofi India (BSE)
peergroup  7787.90 (0.97%)
M.Cap ( in Cr)17936.02
Shareholding Pattern
PROMOTERS 36.2%
NON-INSTITUTION 29.96%
MUTUAL FUNDS/UTI 2.17%
FI/BANKS/INSURANCE 0.24%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
ICICI Pru Pharma He...0.73
About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 391.3. Its current market capitalisation stands at Rs 502.03 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6668.3 Cr and Total Income of Rs.6703.22 Cr. The company's management includes Christopher M Cimarusti, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, William Gordon Mitchell, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are KS Aiyar & Co, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

Directory

current IPO
  • --
upcoming IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room